简体中文 | 繁體中文 | English

Press Releases

2019-10-11 16:41 Värde Partners and Agam Capital Form Life and Retirement Solutions Joint Venture
2019-10-11 16:37 Tej Kohli Foundation advocates a scalable, accessible and affordable technology solution to end corneal blindness worldwide.
2019-10-11 14:47 CSC Introduces New Domain Name Security Intelligence API at the Cyber Defense Summit 2019 Hosted by FireEye
2019-10-11 14:42 Yokogawa Releases Dynamic Real Time Optimizer, a New Solution in the OpreX Asset Operations and Optimization Family
2019-10-11 14:10 Mouser Electronics and Grant Imahara Explore Prototype Design with Arduino in Latest “Engineering Big Ideas” Series Video
2019-10-11 14:04 Federal National Council Launches Arab Charter on Women’s Rights in Cooperation With Arab Parliament
2019-10-11 14:01 Andersen Global Enters Namibia; Continues Expanding Presence in Africa
2019-10-11 13:59 Murata to Develop Millimeter-Wave (60 GHz) RF Module for Terragraph
2019-10-11 12:52 Shiseido to Acquire DRUNK ELEPHANT™
2019-10-11 12:49 GSMA: Russian Mobile Operators to Lead Commonwealth of Independent States in 5G Deployments
2019-10-11 12:44 Project Management Institute Announces the Top 50 Most Influential Projects of the Last 50 Years
2019-10-11 12:41 TÜV Rheinland Commends the State of California Blue Light Resolution; Announces Blue Light Summit With Electronics Manufacturers
2019-10-11 12:35 REDD Intelligence Announces Executive Appointment
2019-10-11 08:01 NTT Delivers Successful Ultra Reality Viewing of Live MLB Postseason Game
2019-10-11 07:40 Elliptic Labs’ AI Virtual Sensor Gives Cleaner Design to New OnePlus 7T Pro 5G Phone
2019-10-10 18:06 Aspect Software Announces Cloud Contact Center v19
2019-10-10 17:49 IDEMIA enters patent license agreement for on-card enrollment solutions with IDEX in order to expand its leadership in the field of biometric cards
2019-10-10 17:43 Kyoto by the Sea: Sacred Motoise Shrine and Nariaiji Temple Transform into an Immersive World of Art
2019-10-10 17:25 PMI Sets Carbon Neutrality Target for All of Its Factories By 2030
2019-10-10 16:29 Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic Dermatitis

Business Wire Weibo

Industries

Latest Releases